de Lima Montalvão, Silmara
Mayo Clinic
Laboratory Hemostasis and Thrombosis, Hematology Center of University of Campinas, Campinas, Brazil.
Citations 2
A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point‐of‐care diagnostics in low‐resource settings
Hagembe, Juliana , Toulon, Pierre , Haffar, Assad, Baumann, Alain, Bowyer, Annette , Montalvão, Silmara Aparecida de Lima , Brasi, Carlos Daniel De , Pierce, Glenn F. , de Lima Montalvão, Silmara , Pierce, Glenn F , Gouider, Emna , Chen, Dong
Haemophilia | September 1, 2023 | Volume: 29 | Issue: 5 | Pages: 1376-1381
International Council for Standardization in Haematology recommendations for laboratory measurement of factorVIIIandFIXtypeIinhibitors
Meijer, Piet , Peyvandi, Flora , Young, Guy , Pruthi, Rajiv K. , Montalvão, Silmara Aparecida de Lima , Kitchen, Steve , Pruthi, Rajiv K , de Lima Montalvão, Silmara , Peyvandi, Flora
International Journal of Laboratory Hematology | June 8, 2023 | Volume: 45 | Issue: 4 | Pages: 413-424
AbstractThis guidance document has been prepared on behalf of the International Council for Standardisation in Hematology. The aim of the document is to provide guidance and recommendations on the measurement of factor VIII (FVIII) and factor IX (FIX) inhibitors. After an introduction on the clinical background and relevance of factor VIII and factor IX inhibitor testing, the following aspects of laboratory testing are included: screening for inhibitors, assay principle, sample requirements, testing requirements and interpretation, quality assurance, interferences and recent developments. This guidance document focusses on recommendations for a standardised procedure for the laboratory measurement of FVIII and FIX type I inhibitors. The recommendations are based on published data in peer‐reviewed literature and expert opinion.